3 hours Q3 2024 EPS Estimates for Moderna, Inc. Decreased by Analyst (NASDAQ:MRNA)MarketBeat
Moderna, Inc. (NASDAQ:MRNA – Free Report) – Analysts at Zacks Research reduced their Q3 2024 earnings per share (EPS) estimates for Moderna in a research report issued to clients and investors on Tuesday, October 15th. Zacks Research analyst S. Gano…
Earnings · Moderna (MRNA) · Nasdaq 100 · Science
X